nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—CHRNB2—autistic disorder	0.331	0.487	CbGaD
Galantamine—CHRNA7—autistic disorder	0.194	0.285	CbGaD
Galantamine—CHRNA4—autistic disorder	0.155	0.228	CbGaD
Galantamine—CHRNB3—pons—autistic disorder	0.0109	0.112	CbGeAlD
Galantamine—CHRNB3—hindbrain—autistic disorder	0.00422	0.0437	CbGeAlD
Galantamine—CHRNG—mouth—autistic disorder	0.00292	0.0302	CbGeAlD
Galantamine—CHRNA4—telencephalic ventricle—autistic disorder	0.00268	0.0277	CbGeAlD
Galantamine—CHRNA5—eye—autistic disorder	0.0026	0.0269	CbGeAlD
Galantamine—CHRNB3—brainstem—autistic disorder	0.00242	0.025	CbGeAlD
Galantamine—CHRNB3—forebrain—autistic disorder	0.00234	0.0242	CbGeAlD
Galantamine—CHRNB3—telencephalon—autistic disorder	0.00215	0.0222	CbGeAlD
Galantamine—CHRNA6—brainstem—autistic disorder	0.00202	0.0209	CbGeAlD
Galantamine—CHRNA6—forebrain—autistic disorder	0.00195	0.0202	CbGeAlD
Galantamine—CHRNA1—mouth—autistic disorder	0.00193	0.02	CbGeAlD
Galantamine—CHRNA6—telencephalon—autistic disorder	0.00179	0.0186	CbGeAlD
Galantamine—CHRNA5—head—autistic disorder	0.00147	0.0152	CbGeAlD
Galantamine—CHRNA5—nervous system—autistic disorder	0.0014	0.0145	CbGeAlD
Galantamine—CHRNA5—central nervous system—autistic disorder	0.00134	0.0139	CbGeAlD
Galantamine—CHRNB3—head—autistic disorder	0.00134	0.0138	CbGeAlD
Galantamine—CHRNB3—nervous system—autistic disorder	0.00127	0.0131	CbGeAlD
Galantamine—CHRNA4—hindbrain—autistic disorder	0.00127	0.0131	CbGeAlD
Galantamine—CHRNB3—central nervous system—autistic disorder	0.00122	0.0126	CbGeAlD
Galantamine—CHRNB3—cerebellum—autistic disorder	0.00119	0.0123	CbGeAlD
Galantamine—CHRNB2—forebrain—autistic disorder	0.00112	0.0116	CbGeAlD
Galantamine—CHRNA6—head—autistic disorder	0.00112	0.0116	CbGeAlD
Galantamine—CHRNA3—eye—autistic disorder	0.0011	0.0113	CbGeAlD
Galantamine—CHRNA3—forebrain—autistic disorder	0.00109	0.0112	CbGeAlD
Galantamine—CHRNA5—brain—autistic disorder	0.00107	0.011	CbGeAlD
Galantamine—CHRNA6—nervous system—autistic disorder	0.00106	0.011	CbGeAlD
Galantamine—CHRNG—head—autistic disorder	0.00105	0.0109	CbGeAlD
Galantamine—CHRNB2—telencephalon—autistic disorder	0.00103	0.0107	CbGeAlD
Galantamine—CHRNA6—central nervous system—autistic disorder	0.00102	0.0105	CbGeAlD
Galantamine—CHRNB4—head—autistic disorder	0.00101	0.0105	CbGeAlD
Galantamine—CHRNA2—forebrain—autistic disorder	0.00101	0.0104	CbGeAlD
Galantamine—CHRNA6—cerebellum—autistic disorder	0.000996	0.0103	CbGeAlD
Galantamine—CHRNB3—brain—autistic disorder	0.000969	0.01	CbGeAlD
Galantamine—CHRNB4—nervous system—autistic disorder	0.000961	0.00994	CbGeAlD
Galantamine—CHRNB1—eye—autistic disorder	0.000948	0.00981	CbGeAlD
Galantamine—CHRNB4—central nervous system—autistic disorder	0.000925	0.00957	CbGeAlD
Galantamine—CHRNA10—head—autistic disorder	0.000893	0.00923	CbGeAlD
Galantamine—Dihydrocodeine—OPRM1—autistic disorder	0.000886	0.222	CrCbGaD
Galantamine—CHRFAM7A—forebrain—autistic disorder	0.000878	0.00909	CbGeAlD
Galantamine—CHRNA6—brain—autistic disorder	0.000809	0.00837	CbGeAlD
Galantamine—CHRFAM7A—telencephalon—autistic disorder	0.000808	0.00836	CbGeAlD
Galantamine—ACHE—telencephalon—autistic disorder	0.000749	0.00775	CbGeAlD
Galantamine—Ethylmorphine—OPRM1—autistic disorder	0.000742	0.186	CrCbGaD
Galantamine—CHRNB4—brain—autistic disorder	0.000735	0.0076	CbGeAlD
Galantamine—CHRNA4—brainstem—autistic disorder	0.000725	0.0075	CbGeAlD
Galantamine—CHRNA7—eye—autistic disorder	0.000716	0.0074	CbGeAlD
Galantamine—CHRNA7—forebrain—autistic disorder	0.000709	0.00734	CbGeAlD
Galantamine—CHRNA4—forebrain—autistic disorder	0.0007	0.00724	CbGeAlD
Galantamine—CHRNA1—head—autistic disorder	0.000697	0.00721	CbGeAlD
Galantamine—Hydrocodone—OPRM1—autistic disorder	0.000679	0.17	CrCbGaD
Galantamine—CHRNA7—telencephalon—autistic disorder	0.000652	0.00675	CbGeAlD
Galantamine—CHRNA4—telencephalon—autistic disorder	0.000644	0.00666	CbGeAlD
Galantamine—CHRNB2—head—autistic disorder	0.000641	0.00663	CbGeAlD
Galantamine—CHRNA3—head—autistic disorder	0.000622	0.00643	CbGeAlD
Galantamine—Oxycodone—OPRM1—autistic disorder	0.00062	0.155	CrCbGaD
Galantamine—CHRNB2—nervous system—autistic disorder	0.000608	0.00629	CbGeAlD
Galantamine—Codeine—OPRM1—autistic disorder	0.000591	0.148	CrCbGaD
Galantamine—CHRNA3—nervous system—autistic disorder	0.00059	0.0061	CbGeAlD
Galantamine—CHRNB2—central nervous system—autistic disorder	0.000585	0.00606	CbGeAlD
Galantamine—CHRNA2—head—autistic disorder	0.000578	0.00598	CbGeAlD
Galantamine—CHRNB2—cerebellum—autistic disorder	0.000572	0.00592	CbGeAlD
Galantamine—CHRNA3—central nervous system—autistic disorder	0.000568	0.00587	CbGeAlD
Galantamine—CHRNA3—cerebellum—autistic disorder	0.000555	0.00574	CbGeAlD
Galantamine—CHRNA2—nervous system—autistic disorder	0.000548	0.00567	CbGeAlD
Galantamine—CHRNB1—head—autistic disorder	0.000538	0.00557	CbGeAlD
Galantamine—CHRNA2—central nervous system—autistic disorder	0.000528	0.00546	CbGeAlD
Galantamine—CHRNA2—cerebellum—autistic disorder	0.000516	0.00534	CbGeAlD
Galantamine—CHRNA1—brain—autistic disorder	0.000505	0.00522	CbGeAlD
Galantamine—CHRFAM7A—head—autistic disorder	0.000503	0.0052	CbGeAlD
Galantamine—CHRNA7—digestive system—autistic disorder	0.000498	0.00515	CbGeAlD
Galantamine—CHRNA4—digestive system—autistic disorder	0.000491	0.00508	CbGeAlD
Galantamine—CHRNB1—cerebellum—autistic disorder	0.00048	0.00497	CbGeAlD
Galantamine—CYP2D6—hindbrain—autistic disorder	0.00048	0.00496	CbGeAlD
Galantamine—Morphine—OPRM1—autistic disorder	0.000478	0.12	CrCbGaD
Galantamine—CHRFAM7A—nervous system—autistic disorder	0.000477	0.00493	CbGeAlD
Galantamine—CHRNB2—brain—autistic disorder	0.000465	0.00481	CbGeAlD
Galantamine—CHRFAM7A—central nervous system—autistic disorder	0.000459	0.00475	CbGeAlD
Galantamine—CHRNA3—brain—autistic disorder	0.000451	0.00466	CbGeAlD
Galantamine—CHRNA2—brain—autistic disorder	0.000419	0.00433	CbGeAlD
Galantamine—ACHE—cerebellum—autistic disorder	0.000416	0.00431	CbGeAlD
Galantamine—BCHE—brainstem—autistic disorder	0.000415	0.00429	CbGeAlD
Galantamine—CHRNA7—head—autistic disorder	0.000406	0.0042	CbGeAlD
Galantamine—CHRNA4—head—autistic disorder	0.000401	0.00415	CbGeAlD
Galantamine—BCHE—forebrain—autistic disorder	0.0004	0.00414	CbGeAlD
Galantamine—CHRNB1—brain—autistic disorder	0.00039	0.00403	CbGeAlD
Galantamine—CHRNA7—nervous system—autistic disorder	0.000385	0.00398	CbGeAlD
Galantamine—CHRNA4—nervous system—autistic disorder	0.00038	0.00393	CbGeAlD
Galantamine—CHRNA7—central nervous system—autistic disorder	0.000371	0.00384	CbGeAlD
Galantamine—BCHE—telencephalon—autistic disorder	0.000368	0.00381	CbGeAlD
Galantamine—CHRNA4—central nervous system—autistic disorder	0.000366	0.00378	CbGeAlD
Galantamine—CHRFAM7A—brain—autistic disorder	0.000365	0.00377	CbGeAlD
Galantamine—CHRNA4—cerebellum—autistic disorder	0.000358	0.0037	CbGeAlD
Galantamine—ACHE—brain—autistic disorder	0.000338	0.0035	CbGeAlD
Galantamine—CHRNA7—brain—autistic disorder	0.000294	0.00305	CbGeAlD
Galantamine—CHRNA4—brain—autistic disorder	0.00029	0.003	CbGeAlD
Galantamine—BCHE—digestive system—autistic disorder	0.000281	0.00291	CbGeAlD
Galantamine—CYP2D6—brainstem—autistic disorder	0.000275	0.00284	CbGeAlD
Galantamine—CYP2D6—forebrain—autistic disorder	0.000265	0.00274	CbGeAlD
Galantamine—CYP2D6—telencephalon—autistic disorder	0.000244	0.00252	CbGeAlD
Galantamine—BCHE—head—autistic disorder	0.000229	0.00237	CbGeAlD
Galantamine—BCHE—nervous system—autistic disorder	0.000217	0.00225	CbGeAlD
Galantamine—BCHE—central nervous system—autistic disorder	0.000209	0.00217	CbGeAlD
Galantamine—BCHE—cerebellum—autistic disorder	0.000205	0.00212	CbGeAlD
Galantamine—CYP3A4—digestive system—autistic disorder	0.000189	0.00196	CbGeAlD
Galantamine—CYP2D6—digestive system—autistic disorder	0.000186	0.00193	CbGeAlD
Galantamine—BCHE—brain—autistic disorder	0.000166	0.00172	CbGeAlD
Galantamine—CYP2D6—head—autistic disorder	0.000152	0.00157	CbGeAlD
Galantamine—CYP3A4—nervous system—autistic disorder	0.000146	0.00151	CbGeAlD
Galantamine—CYP2D6—nervous system—autistic disorder	0.000144	0.00149	CbGeAlD
Galantamine—CYP3A4—central nervous system—autistic disorder	0.000141	0.00146	CbGeAlD
Galantamine—CYP2D6—central nervous system—autistic disorder	0.000139	0.00143	CbGeAlD
Galantamine—CYP2D6—cerebellum—autistic disorder	0.000136	0.0014	CbGeAlD
Galantamine—CYP2D6—brain—autistic disorder	0.00011	0.00114	CbGeAlD
Galantamine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	1.13e-05	5.13e-05	CbGpPWpGaD
Galantamine—CHRNA7—Transmission across Chemical Synapses—MAPK1—autistic disorder	1.12e-05	5.11e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—EIF4E—autistic disorder	1.11e-05	5.07e-05	CbGpPWpGaD
Galantamine—CHRNA1—Transmission across Chemical Synapses—MAPK1—autistic disorder	1.11e-05	5.06e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—DAO—autistic disorder	1.11e-05	5.06e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—DHCR7—autistic disorder	1.09e-05	4.99e-05	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—autistic disorder	1.09e-05	4.98e-05	CbGpPWpGaD
Galantamine—ACHE—Phospholipid metabolism—PTEN—autistic disorder	1.08e-05	4.92e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—UPB1—autistic disorder	1.06e-05	4.85e-05	CbGpPWpGaD
Galantamine—CHRNA2—Transmission across Chemical Synapses—MAPK1—autistic disorder	1.05e-05	4.81e-05	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—IL6—autistic disorder	1.05e-05	4.79e-05	CbGpPWpGaD
Galantamine—CHRND—Transmission across Chemical Synapses—HRAS—autistic disorder	1.05e-05	4.78e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—EXT1—autistic disorder	1.04e-05	4.73e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SLC6A8—autistic disorder	1.04e-05	4.73e-05	CbGpPWpGaD
Galantamine—CHRNB4—Transmission across Chemical Synapses—HRAS—autistic disorder	1.04e-05	4.73e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—RPL10—autistic disorder	1.04e-05	4.73e-05	CbGpPWpGaD
Galantamine—CHRNB2—Neuronal System—HRAS—autistic disorder	1.01e-05	4.6e-05	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—autistic disorder	1.01e-05	4.6e-05	CbGpPWpGaD
Galantamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—autistic disorder	1e-05	4.58e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—BCL2—autistic disorder	1e-05	4.58e-05	CbGpPWpGaD
Galantamine—CHRND—Neuronal System—MAPK1—autistic disorder	9.99e-06	4.56e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—EIF4E—autistic disorder	9.91e-06	4.52e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—DAO—autistic disorder	9.89e-06	4.51e-05	CbGpPWpGaD
Galantamine—CHRNB4—Neuronal System—MAPK1—autistic disorder	9.89e-06	4.51e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTM5—autistic disorder	9.89e-06	4.51e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ASMT—autistic disorder	9.89e-06	4.51e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—IGFBP3—autistic disorder	9.82e-06	4.48e-05	CbGpPWpGaD
Galantamine—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—autistic disorder	9.76e-06	4.45e-05	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—PRKCB—autistic disorder	9.69e-06	4.42e-05	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PTEN—autistic disorder	9.62e-06	4.39e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—MAOB—autistic disorder	9.58e-06	4.37e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—autistic disorder	9.54e-06	4.35e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—UPB1—autistic disorder	9.49e-06	4.33e-05	CbGpPWpGaD
Galantamine—CHRNA3—Transmission across Chemical Synapses—HRAS—autistic disorder	9.48e-06	4.33e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SLC25A12—autistic disorder	9.29e-06	4.24e-05	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—MAPK1—autistic disorder	9.14e-06	4.17e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—PAX6—autistic disorder	9.12e-06	4.16e-05	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—MAPK1—autistic disorder	9.05e-06	4.13e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SLC19A1—autistic disorder	9.04e-06	4.13e-05	CbGpPWpGaD
Galantamine—CHRNA7—Transmission across Chemical Synapses—HRAS—autistic disorder	9e-06	4.11e-05	CbGpPWpGaD
Galantamine—CHRNA1—Transmission across Chemical Synapses—HRAS—autistic disorder	8.9e-06	4.06e-05	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—CYP19A1—autistic disorder	8.87e-06	4.05e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTM5—autistic disorder	8.82e-06	4.02e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ASMT—autistic disorder	8.82e-06	4.02e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—IGFBP3—autistic disorder	8.76e-06	4e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—CYP19A1—autistic disorder	8.75e-06	3.99e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—PRKCB—autistic disorder	8.65e-06	3.95e-05	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—MAPK1—autistic disorder	8.59e-06	3.92e-05	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL6—autistic disorder	8.56e-06	3.91e-05	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—MAPK1—autistic disorder	8.5e-06	3.88e-05	CbGpPWpGaD
Galantamine—CHRNA2—Transmission across Chemical Synapses—HRAS—autistic disorder	8.46e-06	3.86e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—autistic disorder	8.32e-06	3.79e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	8.31e-06	3.79e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SLC25A12—autistic disorder	8.29e-06	3.78e-05	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—COMT—autistic disorder	8.25e-06	3.76e-05	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GSTP1—autistic disorder	8.21e-06	3.75e-05	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—MAOA—autistic disorder	8.19e-06	3.74e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—COMT—autistic disorder	8.14e-06	3.71e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—PAX6—autistic disorder	8.13e-06	3.71e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—GSTP1—autistic disorder	8.1e-06	3.7e-05	CbGpPWpGaD
Galantamine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—autistic disorder	8.1e-06	3.69e-05	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—MAPK1—autistic disorder	8.07e-06	3.68e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SLC19A1—autistic disorder	8.07e-06	3.68e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ADSL—autistic disorder	8.06e-06	3.68e-05	CbGpPWpGaD
Galantamine—CHRND—Neuronal System—HRAS—autistic disorder	8.02e-06	3.66e-05	CbGpPWpGaD
Galantamine—CHRNB4—Neuronal System—HRAS—autistic disorder	7.94e-06	3.62e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—XDH—autistic disorder	7.9e-06	3.61e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—STX1A—autistic disorder	7.76e-06	3.54e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NPAS2—autistic disorder	7.76e-06	3.54e-05	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GSTM1—autistic disorder	7.55e-06	3.44e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—TCN2—autistic disorder	7.49e-06	3.42e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—GSTM1—autistic disorder	7.44e-06	3.4e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	7.41e-06	3.38e-05	CbGpPWpGaD
Galantamine—CHRNA4—Transmission across Chemical Synapses—HRAS—autistic disorder	7.33e-06	3.35e-05	CbGpPWpGaD
Galantamine—CHRNA3—Neuronal System—HRAS—autistic disorder	7.26e-06	3.31e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—PLAUR—autistic disorder	7.26e-06	3.31e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ADSL—autistic disorder	7.19e-06	3.28e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ADA—autistic disorder	7.15e-06	3.26e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	7.06e-06	3.22e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ACADSB—autistic disorder	7.06e-06	3.22e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—INPP1—autistic disorder	7.06e-06	3.22e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—XDH—autistic disorder	7.05e-06	3.22e-05	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—MAPK1—autistic disorder	7e-06	3.19e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—STX1A—autistic disorder	6.92e-06	3.16e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NPAS2—autistic disorder	6.92e-06	3.16e-05	CbGpPWpGaD
Galantamine—CHRNA7—Neuronal System—HRAS—autistic disorder	6.89e-06	3.15e-05	CbGpPWpGaD
Galantamine—CHRNA1—Neuronal System—HRAS—autistic disorder	6.82e-06	3.11e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	6.77e-06	3.09e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	6.76e-06	3.09e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—TCN2—autistic disorder	6.68e-06	3.05e-05	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—autistic disorder	6.56e-06	3e-05	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—MAPK1—autistic disorder	6.52e-06	2.97e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—RORA—autistic disorder	6.52e-06	2.97e-05	CbGpPWpGaD
Galantamine—CHRNA2—Neuronal System—HRAS—autistic disorder	6.48e-06	2.96e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—PLAUR—autistic disorder	6.48e-06	2.96e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—IGF2—autistic disorder	6.46e-06	2.95e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ADA—autistic disorder	6.38e-06	2.91e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	6.3e-06	2.88e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—BTD—autistic disorder	6.29e-06	2.87e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—MAOB—autistic disorder	6.11e-06	2.79e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	6.04e-06	2.75e-05	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—MAPK1—autistic disorder	5.81e-06	2.65e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—RORA—autistic disorder	5.81e-06	2.65e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—APOE—autistic disorder	5.81e-06	2.65e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP19A1—autistic disorder	5.8e-06	2.65e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—IGF2—autistic disorder	5.77e-06	2.63e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP19A1—autistic disorder	5.72e-06	2.61e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—TPH2—autistic disorder	5.68e-06	2.59e-05	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—HRAS—autistic disorder	5.62e-06	2.56e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—DPYD—autistic disorder	5.59e-06	2.55e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—MAOB—autistic disorder	5.45e-06	2.49e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—COMT—autistic disorder	5.39e-06	2.46e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTP1—autistic disorder	5.37e-06	2.45e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—MAOA—autistic disorder	5.36e-06	2.44e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—TDO2—autistic disorder	5.35e-06	2.44e-05	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—POMC—autistic disorder	5.33e-06	2.43e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—COMT—autistic disorder	5.32e-06	2.43e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTP1—autistic disorder	5.29e-06	2.42e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	5.25e-06	2.39e-05	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—HRAS—autistic disorder	5.23e-06	2.39e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CACNA1C—autistic disorder	5.19e-06	2.37e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—APOE—autistic disorder	5.19e-06	2.37e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—TPH2—autistic disorder	5.07e-06	2.31e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—DHCR7—autistic disorder	5.03e-06	2.3e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—LEP—autistic disorder	5.02e-06	2.29e-05	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—MAPK1—autistic disorder	4.99e-06	2.28e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—POMC—autistic disorder	4.99e-06	2.28e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—DPYD—autistic disorder	4.98e-06	2.27e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTM1—autistic disorder	4.93e-06	2.25e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTM1—autistic disorder	4.87e-06	2.22e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—EXT1—autistic disorder	4.77e-06	2.18e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SLC6A8—autistic disorder	4.77e-06	2.18e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—DHFR—autistic disorder	4.72e-06	2.16e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	4.68e-06	2.14e-05	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—HRAS—autistic disorder	4.67e-06	2.13e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CACNA1C—autistic disorder	4.63e-06	2.11e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—INPP1—autistic disorder	4.62e-06	2.11e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ACADSB—autistic disorder	4.62e-06	2.11e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—DAO—autistic disorder	4.55e-06	2.08e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—LEP—autistic disorder	4.48e-06	2.04e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—MAPK1—autistic disorder	4.45e-06	2.03e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—POMC—autistic disorder	4.45e-06	2.03e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—UPB1—autistic disorder	4.36e-06	1.99e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—POMC—autistic disorder	4.31e-06	1.97e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—DHFR—autistic disorder	4.21e-06	1.92e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—IGF1—autistic disorder	4.15e-06	1.89e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—BTD—autistic disorder	4.11e-06	1.88e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTM5—autistic disorder	4.05e-06	1.85e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ASMT—autistic disorder	4.05e-06	1.85e-05	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—HRAS—autistic disorder	4.01e-06	1.83e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	3.98e-06	1.82e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—POMC—autistic disorder	3.85e-06	1.76e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SLC25A12—autistic disorder	3.81e-06	1.74e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SLC19A1—autistic disorder	3.71e-06	1.69e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—IGF1—autistic disorder	3.7e-06	1.69e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP19A1—autistic disorder	3.7e-06	1.69e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—HRAS—autistic disorder	3.58e-06	1.63e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	3.55e-06	1.62e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—TDO2—autistic disorder	3.5e-06	1.6e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—POMC—autistic disorder	3.49e-06	1.59e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	3.47e-06	1.58e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—COMT—autistic disorder	3.44e-06	1.57e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTP1—autistic disorder	3.42e-06	1.56e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—MAOA—autistic disorder	3.42e-06	1.56e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CAT—autistic disorder	3.33e-06	1.52e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ADSL—autistic disorder	3.31e-06	1.51e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP19A1—autistic disorder	3.3e-06	1.51e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—DHCR7—autistic disorder	3.29e-06	1.5e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—XDH—autistic disorder	3.24e-06	1.48e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NPAS2—autistic disorder	3.18e-06	1.45e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—STX1A—autistic disorder	3.18e-06	1.45e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PLA2G4A—autistic disorder	3.15e-06	1.44e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTM1—autistic disorder	3.15e-06	1.44e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—EXT1—autistic disorder	3.12e-06	1.42e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLC6A8—autistic disorder	3.12e-06	1.42e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	3.1e-06	1.41e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—TCN2—autistic disorder	3.07e-06	1.4e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—COMT—autistic disorder	3.07e-06	1.4e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTP1—autistic disorder	3.05e-06	1.39e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—MAOA—autistic disorder	3.05e-06	1.39e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GPX1—autistic disorder	3.01e-06	1.37e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—DAO—autistic disorder	2.97e-06	1.36e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CAT—autistic disorder	2.97e-06	1.36e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ADA—autistic disorder	2.93e-06	1.34e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—UPB1—autistic disorder	2.85e-06	1.3e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PLA2G4A—autistic disorder	2.81e-06	1.28e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTM1—autistic disorder	2.81e-06	1.28e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—MTHFR—autistic disorder	2.78e-06	1.27e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GPX1—autistic disorder	2.69e-06	1.23e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—RORA—autistic disorder	2.67e-06	1.22e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTM5—autistic disorder	2.65e-06	1.21e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ASMT—autistic disorder	2.65e-06	1.21e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—APOE—autistic disorder	2.59e-06	1.18e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—MAOB—autistic disorder	2.51e-06	1.14e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLC25A12—autistic disorder	2.49e-06	1.14e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—MTHFR—autistic disorder	2.48e-06	1.13e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLC19A1—autistic disorder	2.42e-06	1.11e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3CG—autistic disorder	2.34e-06	1.07e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—TPH2—autistic disorder	2.33e-06	1.06e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—APOE—autistic disorder	2.31e-06	1.05e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—DPYD—autistic disorder	2.29e-06	1.05e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—POMC—autistic disorder	2.22e-06	1.01e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ADSL—autistic disorder	2.16e-06	9.86e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CACNA1C—autistic disorder	2.13e-06	9.72e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—XDH—autistic disorder	2.12e-06	9.67e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3CG—autistic disorder	2.08e-06	9.51e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—STX1A—autistic disorder	2.08e-06	9.49e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NPAS2—autistic disorder	2.08e-06	9.49e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—TCN2—autistic disorder	2.01e-06	9.17e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—POMC—autistic disorder	1.98e-06	9.05e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—DHFR—autistic disorder	1.94e-06	8.84e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ADA—autistic disorder	1.92e-06	8.74e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTGS2—autistic disorder	1.77e-06	8.09e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—RORA—autistic disorder	1.75e-06	7.97e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—MAOB—autistic disorder	1.64e-06	7.47e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTGS2—autistic disorder	1.58e-06	7.22e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PTEN—autistic disorder	1.55e-06	7.06e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—TPH2—autistic disorder	1.52e-06	6.95e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP19A1—autistic disorder	1.52e-06	6.92e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—DPYD—autistic disorder	1.5e-06	6.83e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—COMT—autistic disorder	1.41e-06	6.44e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTP1—autistic disorder	1.4e-06	6.41e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—MAOA—autistic disorder	1.4e-06	6.39e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CACNA1C—autistic disorder	1.39e-06	6.35e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PTEN—autistic disorder	1.38e-06	6.3e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CAT—autistic disorder	1.37e-06	6.23e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PLA2G4A—autistic disorder	1.29e-06	5.89e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTM1—autistic disorder	1.29e-06	5.89e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—DHFR—autistic disorder	1.27e-06	5.78e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GPX1—autistic disorder	1.24e-06	5.64e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—MTHFR—autistic disorder	1.14e-06	5.2e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—APOE—autistic disorder	1.06e-06	4.84e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP19A1—autistic disorder	9.92e-07	4.53e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3CG—autistic disorder	9.58e-07	4.37e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—COMT—autistic disorder	9.22e-07	4.21e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTP1—autistic disorder	9.18e-07	4.19e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—MAOA—autistic disorder	9.16e-07	4.18e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—POMC—autistic disorder	9.12e-07	4.16e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CAT—autistic disorder	8.93e-07	4.08e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PLA2G4A—autistic disorder	8.44e-07	3.85e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTM1—autistic disorder	8.44e-07	3.85e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GPX1—autistic disorder	8.08e-07	3.69e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—MTHFR—autistic disorder	7.46e-07	3.4e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTGS2—autistic disorder	7.28e-07	3.32e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—APOE—autistic disorder	6.94e-07	3.17e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PTEN—autistic disorder	6.34e-07	2.89e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3CG—autistic disorder	6.26e-07	2.86e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—POMC—autistic disorder	5.96e-07	2.72e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTGS2—autistic disorder	4.76e-07	2.17e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PTEN—autistic disorder	4.15e-07	1.89e-06	CbGpPWpGaD
